Search Within

Jose Miguel Dominguez Ruiz-tagle

Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (6)
  2. Division of Subspecialty Medicine (6)
  3. Endocrinology (6)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  5. GSK Faculty (5)
  6. Human Oncology and Pathogenesis Program (5)

More Groups

People
  1. James Fagin (5)
  2. Ronald Ghossein (4)
  3. Eric Sherman (3)
  4. Jeffrey Knauf (3)
  5. Robert Tuttle (3)
  6. Agnes Viale (2)

More People

Years
  1. 2014 (1)
  2. 2013 (4)
  3. 2012 (1)
Publications
  1. Journal of Clinical Endocrinology and Metabolism (3)
  2. Cancer Discovery (1)
  3. Cancer Research (1)
  4. New England Journal of Medicine (1)
Publishers
  1. Oxford University Press (3)
  2. American Association for Cancer Research (2)
  3. Massachusetts Medical Society (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Switch in signaling control of mTORC1 activity after oncoprotein expression in thyroid cancer cell lines
    Journal Article

    Malaguarnera, R.; Chen, K.; Kim, T.; Domínguez, J. M.; Voza, F.; Ouyang, B.; Vundavalli, S. K.; Knauf, J. A.; Fagin, J. A.
    Journal of Clinical Endocrinology and Metabolism (2014)

    Fulltext@MSK | Save
  • Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF mutant thyroid carcinomas
    Meeting Abstract

    Montero-Conde, C.; Ruiz-Llorente, S.; Domínguez, J. M.; Knauf, J. A.; Viale, A.; Sherman, E. J.; Ryder, M.; Ghossein, R. A.; Rosen, N.; Fagin, J. A.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases
    Journal Article

    Sabra, M. M.; Domínguez, J. M.; Grewal, R. K.; Larson, S. M.; Ghossein, R. A.; Tuttle, R. M.; Fagin, J. A.
    Journal of Clinical Endocrinology and Metabolism (2013)

    Fulltext@MSK | Save
  • Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF -mutant thyroid carcinomas
    Journal Article

    Montero-Conde, C.; Ruiz-Llorente, S.; Domínguez, J. M.; Knauf, J. A.; Viale, A.; Sherman, E. J.; Ryder, M.; Ghossein, R. A.; Rosen, N.; Fagin, J. A.
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients
    Journal Article

    Robenshtok, E.; Fish, S.; Bach, A.; Domínguez, J. M.; Shaha, A.; Tuttle, R. M.
    Journal of Clinical Endocrinology and Metabolism (2012)

    Fulltext@MSK | Save